Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018163

« Back to Dashboard
NDA 018163 describes RESTORIL, which is a drug marketed by Mallinckrodt Inc and is included in one NDA. It is available from four suppliers. Additional details are available on the RESTORIL profile page.

The generic ingredient in RESTORIL is temazepam. There are seven drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the temazepam profile page.

Summary for NDA: 018163

Mallinckrodt Inc
Formulation / Manufacturing:see details

Pharmacology for NDA: 018163


Suppliers and Packaging for NDA: 018163

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CAPSULE;ORAL 018163 NDA KAISER FOUNDATION HOSPITALS 0179-0045 0179-0045-70 30 CAPSULE in 1 BOX, UNIT-DOSE (0179-0045-70)
CAPSULE;ORAL 018163 NDA Mallinckrodt, Inc. 0406-9914 0406-9914-03 30 CAPSULE in 1 BOTTLE (0406-9914-03)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength15MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength30MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength7.5MG
Approval Date:Oct 25, 1991TE:ABRLD:No

Expired Orange Book Patents for NDA: 018163

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mallinckrodt Inc
CAPSULE;ORAL018163-003Oct 25, 19915,030,632► subscribe
Mallinckrodt Inc
CAPSULE;ORAL018163-003Oct 25, 19915,326,758► subscribe
Mallinckrodt Inc
CAPSULE;ORAL018163-003Oct 25, 19915,211,954► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.